Article · 1 Jun 2026
Conference abstractPublished 12 Nov 2018
Parkinson's disease
Associate professor, Dept. Of medical biochemistry, govt.medicalcollege, amritsar
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily presents with features of bradykinesia, rigidity and tremor, and has, as part of its core pathology, the degeneration of dopaminergic neurons in the substantia nigra pars compacta. There is a great need for the development of a reliable diagnostic tool to improve promptness of diagnosis, definition of disease subtypes, and to monitor disease progression and demonstrate treatment efficacy in the case of disease modifying therapies. Biomarkers are characteristics that can be measured as an indicator of a normal biological process, and they have special relevance in Parkinson’s disease. We currently have no definitive diagnostic test, and thus for the clinician there is hope that biomarkers will help diagnose symptomatic and presymptomatic disease or provide surrogate end-points to demonstrate clinical efficacy of new treatments, such as neuroprotective therapies, and help stratify this heterogeneous disease. No biomarker is likely to fulfill all these functions, so we need to know how each has been validated in order to understand their uses and limitations, and be aware of potential pitfalls. In this review we discuss the current potential biomarkers for Parkinson’s disease, highlight the problems with their use, and conclude with a discussion of future alternatives. Current biomarkers range from objective clinical tools, to neuroimaging, to 'wet' markers involving blood and cerebrospinal fluid. To date, all candidate biomarkers for PD have failed to be developed into a clinically useful tool. Ideally, a combination of sensitive markers will be needed, not only to predict the onset of PD, but also to help in subtype classification and to follow progression. Here, we critically review various PD biomarker studies.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 22 Dec 2025
Neuroinflammation in Parkinson’s disease (PD)
Editorial · 30 Oct 2025
Parkinson’s Disease: Mechanisms, Management, and Future Directions
Article · 28 Jul 2025
A Potential Clinical Index for Parkinson's Disease Using Human Brain Magnetic Resonance Imaging
Case report · 30 Jun 2025
A Clinical Case Report on Progressive Parkinson’s Disease with Motor and Non-Motor Manifestations
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Anil Batta”
